In vitro and in vivo evaluation of resveratrol and 3,5-dihydroxy-4'- acetoxy-trans-stilbene in the treatment of human prostate carcinoma and melanoma

Journal of Surgical Research

Volumn 179, Issue 1, 2013, Pages

  Osmond, Gregory W ^a   Masko, Elizabeth M ^a   Tyler, Douglas S ^a,b   Freedland, Stephen J ^a,b   Pizzo, Salvatore ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

3,5,4' trihydroxy trans stilbene; 3,5 dihydroxy 4' acetoxy trans stilbene; 4' acetoxy resveratrol; Melanoma; Prostate carcinoma; Resveratrol

Indexed keywords

3,5 DIHYDROXY 4' ACETOXY TRANS STILBENE; CYCLINE; DIMETHYL SULFOXIDE; MACROGOL; RESVERATROL; STILBENE; UNCLASSIFIED DRUG; 3,5 DIHYDROXY 4 ETHYLSTILBENE; 3,5-DIHYDROXY-4-ETHYLSTILBENE; ANTINEOPLASTIC AGENT; STILBENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CONTROLLED STUDY; CYTOTOXICITY; DRUG BLOOD LEVEL; DRUG MECHANISM; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; TUMOR GROWTH; ANIMAL; CELL PROLIFERATION; DISEASE MODEL; DOSE RESPONSE; DRUG SCREENING; NUDE MOUSE; PATHOLOGY; PROSTATE TUMOR; SKIN TUMOR; TIME; TREATMENT OUTCOME; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE; MELANOMA; MICE; MICE, NUDE; PROSTATIC NEOPLASMS; SKIN NEOPLASMS; STILBENES; TIME FACTORS; TREATMENT OUTCOME; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84870705922     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2012.02.057     Document Type: Article

References (23)

1. M. Jang, L. Cai, and G.O. Udeani Cancer chemopreventive activity of resveratrol, a natural product derived from grapes Science 275 1997 218
2. S. Bradamante, L. Barenghi, and A. Villa Cardiovascular protective effects of resveratrol Cardiovasc Drug Rev 22 2004 169
3. K. Sinha, G. Chaudhary, and Y.K. Gupta Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats Life Sci 71 2002 655
4. Q. Wang, J. Xu, and G.E. Rottinghaus Resveratrol protects against global cerebral ischemic injury in gerbils Brain Res 958 2002 439
5. J.A. Baur, and D.A. Sinclair Therapeutic potential of resveratrol: The in vivo evidence Nat Rev Drug Discov 5 2006 493
6. S. Yang, K. Irani, and S.E. Heffron Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE/Ref-1) in human melanoma and identification of the therapeutic potential of resveratrol as an APE/Ref-1 inhibitor Mol Cancer Ther 4 2005 1923
7. T.T. Wang, N.W. Schoene, and Y.S. Kim Differential effects of resveratrol and its naturally occurring methylether analogs on cell cycle and apoptosis in human androgen-responsive LNCaP cancer cells Mol Nutr Food Res 54 2010 335
8. M.H. Aziz, M. Nihal, and V.X. Fu Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3'-kinase/Akt pathway and Bcl-2 family proteins Mol Cancer Ther 5 2006 1335
9. Y. Wong, G. Osmond, and K.I. Brewer Synthesis of 4'-ester analogs of resveratrol and their evaluation in malignant melanoma and pancreatic cell lines Bioorg Med Chem Lett 20 2010 1198
10. G.W. Osmond, C.K. Augustine, and P.A. Zipfel Enhancing melanoma treatment with resveratrol J Surg Res 172 2012 109 Epub 2010 August 6
11. H. Yang, J.A. Baur, and A. Chen Design and synthesis of compounds that extend yeast replicative lifespan Aging Cell 6 2007 35
12. J.C. Mavropoulos, W.C. Buschemeyer 3rd, and A.K. Tewari The effects of varying dietary carbohydrate and fat content on survival in a murine LNCaP prostate cancer xenograft model Cancer Prev Res (Phila) 2 2009 557 Epub 2009 May 26
13. J.A. Thomas, J.A. Antonelli, and J.C. Lloyd Effect of intermittent fasting on prostate cancer tumor growth in a mouse model Prostate Cancer and Prostatic Dis 13 2010 350 doi:10.1038/pcan.2010.24 published online 24 August 2010
14. T. Mossman Rapid colorimetric assay for cellular growth and survivals: Application to proliferation and cytotoxicity assays J Immunol Methods 65 1983 55
15. T. Walle, F. Hsieh, and M. DeLegge High absorption but very low bioavailability of oral resveratrol in humans Drug Metab Dispos 32 2004 1377
16. S.N. Pinchot, R. Jaskula-Sztul, and L. Ning Identification and validation of Notch pathway activating compounds through a novel high-throughput screening method Cancer 117 2011 1386
17. M. Truong, M.R. Cook, and S.N. Pinchot Resveratrol induces Notch2-mediated apoptosis and suppression of neuroendocrine markers in medullary thyroid cancer Ann Surg Oncol 18 2011 1506
18. E. Wenzel, T. Soldo, and H. Erbersdobler Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats Mol Nutr Food Res 49 2005 482
19. P. Ferrer, M. Asensi, and R. Segarra Association between pterostilbene and quercetin inhibits metastatic activity of B16 melanoma Neoplasia 7 2005 37
20. R.M. Niles, C.P. Cook, and G.G. Meadows Resveratrol is rapidly metabolized in athymic mice and does not inhibit human melanoma xenograft tumor growth J Nutr 136 2006 2542
21. A.W. Opipari Jr., L. Tan, and A.E. Boitano Resveratrol-induced autophagocytosis in ovarian cancer cells Cancer Res 64 2004 696
22. A. Crozier, G. Borges, and D. Ryan The glass that cheers: Phenolic and polyphenolic constituents and the beneficial effects of moderate red wine consumption The Biochemist 32 2010 4
23. M. Pacholec, J.E. Bleasdale, and B. Chrunyk SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1 J Biol Chem 285 2010 8340 Epub 2010 January 8